Aethlon Medical, Inc. announced that Laszlo Radvanyi, Ph.D., an Associate Professor in the Department of Melanoma Medical Oncology Research at the University of Texas MD Anderson Cancer Center in Houston, has joined its Scientific Advisory Board. After completing postdoctoral work in Toronto and at Harvard University in Boston at the Joslin Diabetes Center, Dr. Radvanyi joined the Immunology Group at Sanofi-Pasteur in Toronto in 2000 as a Senior Scientist. In 2005, Dr. Radvanyi joined the faculty of the University of Texas, MD Anderson Cancer Center, where he also holds the additional appointment as Associate Professor, Department of Breast Medical Oncology, Division of Cancer Medicine.
Market Closed -
Other stock markets
|
After market 16:32:49 | |||
0.5605 USD | -4.34% | 0.552 | -1.52% |
06-03 | Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies | CI |
05-15 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.41% | 5.41M | |
+9.55% | 222B | |
+14.41% | 195B | |
+24.02% | 148B | |
+33.92% | 113B | |
+4.18% | 66.45B | |
+12.92% | 53.11B | |
+3.16% | 50.03B | |
-4.32% | 38.8B | |
-1.99% | 34.85B |
- Stock Market
- Equities
- AEMD Stock
- News Aethlon Medical, Inc.
- Aethlon Medical, Inc. Names Laszlo Radvanyi to Scientific Advisory Board